Charles Q. Morris

Charles Q. Morris discloses dealings in 3 companies, chiefly Allos Therapeutics Inc, ImmunoGen, Inc. and Radius Health, Inc. We count 26 filings; the first trade dates from 20 October 2010 and the latest from 26 February 2020.

No open-market purchase appears, only 15 sales worth €701k. Other entries cover 6 share grants and 4 option exercises. 2020 to date brings no purchases and 1 sale.

On 28 February 2020 came the latest disclosure, an open-market sale for €21k in Radius Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.